Cotranslational Protein Expression System for High-throughput Screening

Description:
Reporter gene-based assays are used extensively in high-throughput screening (HTS) to identify chemical modulators of cellular pathways for drug discovery and development. However, such screening frequently results in a large number of false “hits” due to interactions of screened compounds with reporter proteins, producing confounding results. Thus, validation of results using these assays often involves significant time and expense.

The inventors have developed an assay system that significantly improves detection of target-relevant active compounds by discriminating between signals arising from the target activity and those caused by reporter bias. This system utilizes simultaneous detection (also known as “coincidence detection”) of non-homologous reporter proteins with dissimilar properties, such as differing catalysis, light emission, or fluorescence characteristics; simultaneous observation of signals from these reporters indicates a high probability that it is a true target response. The reporters are cotranslationally expressed from a single RNA transcript, which ensures stable stoichiometry of the expressed proteins.
Patent Information:
Category(s):
Collaboration
For Information, Contact:
Ami Gadhia
Technolgy and Patent Specialist
NIH Technology Transfer
301-827-7159
ami.gadhia@nih.gov
Inventors:
Chih-Chien (Ken) Cheng
Samuel Hasson
James Inglese
Keywords:
AC4XXX
ACXXXX
AXXXXX
Coincidence
drug discovery
Drug Screening
High-throughput
High-throughput screen
HTS
REPORTER
reporter gene
© 2024. All Rights Reserved. Powered by Inteum